Anti-metastatic activity, chemotherapeutic enhancement and therapeutic potential of targeting Hsp90 with ganetespib in triple negative breast cancer

被引：0
|
作者：
Proia, D. A. [1 ]
Zhang, C. [1 ]
Sequeira, M. [1 ]
Jimenez, J-P [1 ]
He, S. [1 ]
Nagai, M. [1 ]
Acquaviva, J. L. [1 ]
Smith, D. L. [1 ]
Sang, J. [1 ]
El-Hariry, I. [1 ]
机构：
[1] Synta Pharmaceut, Lexington, MA USA
来源：
CANCER RESEARCH | 2013年 / 73卷
关键词：
D O I：
10.1158/0008-5472.SABCS13-PD5-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PD5-3
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Preclinical Activity Profile and Therapeutic Efficacy of the HSP90 Inhibitor Ganetespib in Triple-Negative Breast Cancer
    Proia, David A.
    Zhang, Chaohua
    Sequeira, Manuel
    Jimenez, John-Paul
    He, Suqin
    Spector, Neil
    Shapiro, Geoffrey I.
    Tolaney, Sara
    Nagai, Masazumi
    Acquaviva, Jaime
    Smith, Donald L.
    Sang, Jim
    Bates, Richard C.
    El-Hariry, Iman
    CLINICAL CANCER RESEARCH, 2014, 20 (02) : 413 - 424
  • [2] Potential Value of HSP90 a in Prognosis of Triple-Negative Breast Cancer
    Wang, Han Fei
    Chen, Ying
    Cao, Bang
    Pei, Jing
    MEDICAL SCIENCE MONITOR, 2024, 30
  • [3] Targeting Hsp90 affects stem cell signaling in triple negative breast cancer
    Ramamoorthy, Prabhu
    Rangarajan, Parthasarathy
    Jensen, Roy
    Anant, Shrikant
    CANCER RESEARCH, 2016, 76
  • [4] Targeting HSP90 with ganetespib for targeted therapy of gastric cancer
    Liu, Hanqing
    Zhang, Peishan
    Liang, Zhiquan
    Ruan, Lingling
    Lian, Caixia
    Lu, Jian
    Hua, Ye
    Shi, Haifeng
    Chen, Keping
    Tu, Zhigang
    MOLECULAR CANCER RESEARCH, 2016, 14
  • [5] The C-terminal HSP90 inhibitor, a novel deguelin derivative, exerts anti-metastatic effects in triple-negative breast cancer by targeting cancer stem-like properties
    Park, Minsu
    Cho, Tae-Min
    Park, Soeun
    Park, Jung Min
    Seo, Juyeon
    Ko, Dongmi
    Kim, Seongjae
    Seuk, So Ra
    Kang, Yong Gu
    Nam, Kee Dal
    Kim, Yoon-Jae
    Kim, Ji Young
    Seo, Jae Hong
    CANCER RESEARCH, 2022, 82 (12)
  • [6] Targeting the chaperone Hsp90 to activate the immune system and eradicate the triple negative breast cancer
    Eisa, Nada
    Crowley, Vincent M.
    Elahi, Asif
    Kommalapati, Vamsi K.
    Korkaya, Hasan
    Debbab, Abdessamad
    Blagg, Brian
    Chadli, Ahmed
    CANCER RESEARCH, 2023, 83 (07)
  • [7] Antiangiogenic activity of the HSP90 inhibitor ganetespib in pancreatic cancer models
    Ganji, Purnachandra Nagaraju
    Diaz, Roberto
    El-Rayes, Bassel
    FASEB JOURNAL, 2013, 27
  • [8] Effects of Hsp90 inhibitors on triple negative breast cancer: BRCA1 as a therapeutic target for TNBC
    Ramamoorthy, Prabhu
    Rangarajan, Parthasarathy
    Tawfik, Ossama
    Anant, Shrikant
    Jensen, Roy A.
    CANCER RESEARCH, 2016, 76
  • [9] C-terminal HSP90 inhibitor L80 elicits anti-metastatic effects in triple-negative breast cancer via STAT3 inhibition
    Cho, Tae-Min
    Kim, Ji Young
    Kim, Yoon-Jae
    Sung, Daeil
    Oh, Eunhye
    Jang, Seojin
    Farrand, Lee
    Van-Hai Hoang
    Cong-Truong Nguyen
    Ann, Jihyae
    Lee, Jeewoo
    Seo, Jae Hong
    CANCER LETTERS, 2019, 447 : 141 - 153
  • [10] Anti-metastatic Effects of Nitric Oxide in Triple Negative Breast Cancer (TNBC)
    Sahni, Sumit
    Hickok, Jason
    Thomas, Douglas D.
    FREE RADICAL BIOLOGY AND MEDICINE, 2010, 49 : S69 - S69
12345